Poor health-related quality of life in postural orthostatic tachycardia syndrome in comparison with a sex- and age-matched normative population. — CFSMEATLAS
Poor health-related quality of life in postural orthostatic tachycardia syndrome in comparison with a sex- and age-matched normative population.
Seeley, Marie-Claire, Gallagher, Celine, Ong, Eric et al. · Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2023 · DOI
Quick Summary
This study compared quality of life in people with POTS (a condition causing rapid heartbeat when standing) to people without POTS. Researchers found that people with POTS reported significantly worse quality of life across all areas tested, including mobility, self-care, daily activities, pain, and mood. The impact was consistent across all age groups, and was worse in people with severe symptoms, women, those with fatigue, and those who also had ME/CFS.
Why It Matters
This study is important because it quantifies the significant functional burden of POTS, a condition that commonly co-occurs with ME/CFS. The finding that ME/CFS comorbidity independently worsens quality of life in POTS suggests these conditions have compounding effects on daily functioning. Understanding the magnitude of HrQoL impairment helps validate patient experiences and may inform clinical prioritization and treatment strategies.
Observed Findings
POTS participants showed significantly higher burden of impairment across all five EQ-5D-5L domains compared to normative controls (p<0.001).
Median EQ-VAS (global health rating) was significantly lower in POTS than controls (p<0.001).
Utility scores (overall health-related quality of life measure) were significantly lower in POTS across all age groups (p<0.001).
Severity of orthostatic intolerance symptoms, female sex, high fatigue scores, and comorbid ME/CFS independently predicted lower quality of life in POTS.
Quality of life impairment in POTS was less severe than in many other chronic health conditions, though still substantial.
Inferred Conclusions
POTS causes universal, clinically meaningful impairment in health-related quality of life across multiple functional domains compared to healthy individuals.
The impact of POTS on quality of life is compounded by female sex, high fatigue burden, and comorbid ME/CFS diagnosis.
Orthostatic intolerance symptom severity is a key modifiable target for improving quality of life in POTS patients.
Remaining Questions
What longitudinal changes in quality of life occur over time in POTS, and do they correlate with treatment responses?
What This Study Does Not Prove
This cross-sectional study cannot establish causation or whether POTS causes reduced quality of life or vice versa. It does not prove that treating POTS symptoms will improve quality of life, only that the conditions are associated with worse outcomes. The predominantly female sample (90.6%) limits generalizability to male POTS patients.